Loading organizations...

Alto Pharmacy: A full-service digital pharmacy providing prescription delivery directly to patients' doors, simplifying medication access for patients.
Based in San Francisco, California, Alto Pharmacy is a digital pharmacy platform that provides prescription fulfillment, medication management software, and same-day delivery services directly to patients. The company operates as a full-service retail pharmacy across 13 United States markets, having successfully delivered over four million prescriptions to hundreds of thousands of individual users. Alto Pharmacy has reached a unicorn valuation exceeding $1 billion after securing approximately $580 million in total venture funding, which includes a $200 million Series E financing round. The enterprise currently employs over 1,000 people under the leadership of former Amazon executive Alicia Boler Davis, and is backed by prominent institutional investors such as SoftBank Vision Fund, Greenoaks Capital, and Jackson Square Ventures. The healthcare technology company was originally established under the name ScriptDash in 2015 by co-founders Jamie Karraker and Mattieu Gamache-Asselin.
Alto Pharmacy has raised $323.6M across 5 funding rounds.
Alto Pharmacy has raised $323.6M in total across 5 funding rounds.
Alto Pharmacy has raised $323.6M in total across 5 funding rounds.
Alto Pharmacy's investors include SoftBank, Hack VC, Javelin Venture Partners, MHS Capital, Turtle Ventures, Greenoaks Capital, Jackson Square Ventures, Olive Tree Capital, Zola Global, Flint Capital, Glilot Capital Partners, NFX.
Alto Pharmacy is a technology-driven pharmacy company that builds an integrated platform combining AI, automation, and pharmacist expertise to streamline prescription fulfillment, delivery, and patient care. It serves patients seeking convenient home delivery of medications, physicians managing workflows, and enterprise partners like telehealth providers, hubs, and payors, solving problems like slow prescription processing, high costs, manual errors, and poor adherence through high-volume fulfillment centers and tools like the Alto patient app and Alto Connect.[1][2][3]
Key offerings include Alto Technologies, launched in 2024, featuring Alto Complete™ (an end-to-end hub and dispensing platform), Alto Hub+™ (non-dispensing automation for billing and access), and retail/specialty dispensing with same-day delivery. This has driven growth momentum: 41% of prescriptions ready in 2 minutes, 70-75% in 60 minutes, $220M+ in patient savings via automated insurance and coupons, and 85% app adoption, enabling one fulfillment center to serve as many as 400 chain pharmacies.[1][2][3]
Founded in 2015 in San Francisco, Alto Pharmacy emerged from founders' recognition that legacy pharmacy tech—reliant on manual processes—delivered slow fills, high costs, and limited delivery, failing patients' needs for quality care.[1][3] Over nearly a decade, Alto developed its proprietary Alto OS™ operating system in-house to prioritize patients, blending tech efficiencies with pharmacist input while expanding from direct-to-consumer delivery in metro areas like San Francisco (7M people), Los Angeles, and Orange County (20M people) to high-volume fulfillment centers.[1][3]
Pivotal moments include building specialized expertise in complex therapeutics (e.g., fertility, psychiatry, HIV) and launching Alto Technologies in October 2024 to license its platform enterprise-wide, evolving from a patient-facing pharmacy to a B2B tech provider after proving internal traction like rapid delivery and massive savings.[1][4]
Alto stands out in pharmacy through automation-first tech that replaces manual workflows, enabling superior speed, cost, and adherence:
Alto rides the digital health and telehealth boom, capitalizing on post-pandemic demand for convenient, tech-enabled care amid rising chronic disease management and specialty drug needs. Timing aligns with AI/automation maturation in healthcare, where outdated pharmacy systems create friction—Alto's platform addresses this by modernizing the $500B+ U.S. pharmacy market with end-to-end digitization.[1][3]
Market forces favoring Alto include payer pressures for adherence/cost reduction, telehealth growth needing integrated fulfillment, and specialty "lite" opportunities via low-cost hubs. It influences the ecosystem by enabling partners (manufacturers, payors, DTC brands) to scale access, cut admin burdens, and unlock data insights, potentially disrupting chains like CVS while humanizing care through pharmacist-tech synergy.[1][2][4][5]
Alto's pivot to Alto Technologies positions it for B2B expansion, licensing its proven platform to telehealths, hubs, and networks amid AI-driven pharmacy modernization. Upcoming trends like personalized medicine, further automation (e.g., advanced AI for adherence), and regulatory tailwinds for DTC delivery will accelerate growth, potentially multiplying enterprise partnerships and nationwide scaling beyond current metros.[1][2]
As pharmacy tech evolves, Alto could redefine standards for convenience and equity in medication access, evolving from disruptor to infrastructure layer—much like how its 2015 origins transformed patient experiences, now empowering the industry's shift to patient-first efficiency.
Alto Pharmacy has raised $323.6M across 5 funding rounds. Most recently, it raised $250.0M Series D in January 2020.